Genitourinary syndrome of menopause
===================================


In the article by [A.C. Moreno, S.K. Sikka, and H.L. Thacker, Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available, Cleve Clin J Med 2018; 85(10):760–766, doi:10.3949/ccjm.85a.17108](http://www.ccjm.org/lookup/doi/10.3949/ccjm.85a.17108)), Table 2 incorrectly stated that prasterone is contraindicated in women with known or suspected breast cancer. This correction has been made online. The corrected table appears below:

View this table:
[TABLE 2](http://www.ccjm.org/content/85/11/860/T1)

TABLE 2 
FDA-approved labeling notes for treatments for genitourinary syndrome of menopause

*   Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.